Bloomberg Law
Aug. 30, 2016, 6:23 PM UTC

Are More ‘Purple Pill’ Lawsuits Around the Corner?

Bloomberg Law - Staff Reports

By Julie A. Steinberg, Bloomberg BNA

AstraZeneca’s “purple pill” Nexium caused an Illinois man’s kidney disease, according to the latest suit in what could be a new wave of litigation.

The plaintiff George Mullen sued last week in federal court in Brooklyn and accused AstraZeneca Pharmaceuticals LP and AstraZeneca LP of failing to warn that Nexium, a proton pump inhibitor (PPI) prescribed for stomach and other digestive problems, could cause kidney damage.

Mullen alleges he developed chronic kidney disease, or gradual loss of kidney function, after taking prescription Nexium for several years.

His attorney Daniel Burke, of Bernstein Liebhard in New York, said his firm has had several hundred ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.